
Metro International Biotech Begins Phase 1a Trial of NAD Booster MIB-725
Metro International Biotech Begins Phase 1a Trial of NAD Booster MIB-725 Metro International Biotech, LLC (MetroBiotech), a pioneering company in the development of next-generation therapies for age-associated diseases, has officially…












